Key result
A review of current literature on diuretics, vasodilators, and inotropes provides objective evidence and expert opinion to guide the management of patients with decompensated heart failure.
This review summarizes the available objective evidence and expert opinion on the use of diuretics, vasodilators, and inotropes for managing decompensated heart failure.
Answers are grounded in this paper and cite their sources.
Offers limited guidance for decompensated HF; leaves open the need for RCTs on vasodilators and inotropes.
Much has been written about the management of chronic heart failure (HF) and there is strong evidence from many controlled, multicenter trials to support a specific strategy for management of compensated HF. There is little evidence and limited guidance for the management of patients during a period of decompensation. The use of diuretics, inodilators, and vasodilators is based primarily on anecdotal observation. This article reviews selected current literature in three areas (diuretics, vasodilators, and inotropes) to examine objective evidence and expert opinion that are available to guide the advanced practitioner who manages the care of patients with decompensated HF.
No takes yet. Share an insight, caveat, or question.
Kay Branum (2003) conducted a review in Decompensated Heart Failure. Diuretics, vasodilators, and inotropes was evaluated. A review of current literature on diuretics, vasodilators, and inotropes provides objective evidence and expert opinion to guide the management of patients with decompensated heart failure.
Synapse has enriched 10 related papers. Consider them for comparative context: